7 Recommendations To Consider When Vetting eCOA Technology Solutions

By J.C. Wilson, Senior Director, Patient Centered Technologies Product & Engineering, IQVIA

When sponsors and sites embrace decentralized clinical trial models, electronic clinical outcome assessments are among the first tools they adopt. These platforms automate the collection of the patient’s experiences through robust and reliable measures, providing real-time quantitative and qualitative insights. eCOAs also make it easier for patients and caregivers to share information in real-time about the treatment experience without the added burden of constant site visits.

But, as with any technology used in clinical research, choosing the right vendor, solution, and deployment model is critical for success. eCOAs may seem like simple enough tools to deploy in a trial setting, but this isn’t a one size fits all solution that can be rolled out the day a trial goes live. Every application must be customized to the needs of the sponsors, the site staff, and the patients, with features and options designed to ensure data can be securely collected and reviewed with minimal disruption to users.

Sponsors vetting an eCOA technology solution eCOA for their next trial should consider these seven best practices from IQVIA eCOA expert J.C. Wilson. He dives into not only focusing on sponsor needs, but also ensuring that patient needs, site needs, and data considerations have been made.